Litcius/Paper detail

Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease

Waseem Amjad, Joseph J. Alukal, Talan Zhang, Anurag Maheshwari, Paul J. Thuluvath

2020Digestive Diseases and Sciences43 citationsDOI

Topics & Concepts

MedicineInternal medicineHepatitis B virusCirrhosisHepatitis BHepatologyGastroenterologyRegimenSeroconversionVaccinationHepatitis B vaccineImmunologyAntibodyHBsAgVirusHepatitis B Virus StudiesHepatitis C virus researchHepatitis Viruses Studies and Epidemiology
Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease | Litcius